Clinical Trials
3 trialsNCT07218913 2026-04-17
Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
City of Hope Medical Center
Phase 1 Recruiting
NCT02094625 2023-04-18
NAC to Prevent Cisplatin-induced Hearing Loss
Children's Hospital Los Angeles
Phase 1 Completed
NCT00584155 2015-05-27
Protection From Cisplatin Ototoxicity by Lactated Ringers
University of Oklahoma
Phase 1 Withdrawn